The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term Survivor.
Jiang, Y; Firan, M; Nandiwada, SL; Reyes, A; Marsh, RA; Vogel, TP; Hajjar, J.
Case Reports in Immunology.
2020;
2020:8841571-9.
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al.
Bone Marrow Transplantation.
2020;
55:1552-1559.
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis.
Blincoe, A; Heeg, M; Campbell, PK; Hines, M; Khojah, A; Klein-Gitelman, M; Talano, J; Speckmann, C; Touzot, F; Lankester, A; et al.
Journal of Clinical Immunology.
2020;
40:901-916.
Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders.
Vander Lugt, MT; Chen, X; Escolar, ML; Carella, BA; Barnum, JL; Windreich, RM; Hill, MJ; Poe, M; Marsh, RA; Stanczak, H; et al.
Blood Advances.
2020;
4:3041-3052.
Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders.
Gadoury-Levesque, V; Dong, L; Su, R; Chen, J; Zhang, K; Risma, KA; Marsh, RA; Sun, M.
Blood Advances.
2020;
4:2578-2594.
Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience.
Teusink-Cross, A; Davies, SM; Grimley, MS; Chandra, S; Flannery, A; Dandoy, CE; Nelson, AS; Marsh, RA; Jacoby, B; Lane, A; et al.
Pediatric Transplantation.
2020;
24.
Pediatric hemophagocytic lymphohistiocytosis.
Canna, SW; Marsh, RA.
Blood.
2020;
135:1332-1343.
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.
Chan, AY; Leiding, JW; Liu, X; Logan, BR; Burroughs, LM; Allenspach, EJ; Skoda-Smith, S; Uzel, G; Notarangelo, LD; Slatter, M; et al.
Frontiers in Immunology.
2020;
11.
CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells.
Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al.
Biology of Blood and Marrow Transplantation.
2020;
26:1-6.
The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1).
Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA.
Journal of Clinical Immunology.
2019;
39:857-859.